Dr. Sanjay Chandrasekaran, MD is a medical oncologist in Dallas, TX specializing in medical oncology and adult oncology. He graduated from University of Washington School of Medicine in 2014 and has 10 years of experience. Dr. Sanjay Chandrasekaran, MD is affiliated with UT Southwestern Medical Center.
2201 Inwood Road 3rd Floor -- Nc3.500
Dallas, TX 75390
6202 Harry Hines Boulevard 9th Floor
Dallas, TX 75235
Volume of procedures performed by Dr. Sanjay Chandrasekaran, MD for Medicare patients.
The highest averages for the top procedures that Dr. Sanjay Chandrasekaran, MD treated as a medical oncologist in Dallas, TX were hospital care and inpatient care.
| 235 | |
| 15 | |
| 15 |
Dr. Sanjay Chandrasekaran, MD graduated from University of Washington School of Medicine in 2014. He completed residency at Emory University Affiliated Hospitals. He has a state license in Texas.
Medical School: University of Washington School of Medicine (2014)
Residency: Emory University Affiliated Hospitals (2016)
Licensed In: Texas
Dr. Sanjay Chandrasekaran, MD is associated with these hospitals and organizations:
Dr. Sanjay Chandrasekaran, MD does not have any reviews yet, be the first to leave a review of Dr. Sanjay Chandrasekaran, MD here: Leave a Review
These charts describe general payments received by Dr. Sanjay Chandrasekaran, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$142
KIMMTRAK $142 |
|
|
$81
$81 |
|
|
$81
Braftovi $81 |
|
|
$67
$67 |
|
|
$45
$45 |
|
|
$25
NephroCheck Test $25 |
| $441 |
Dr. Sanjay Chandrasekaran, MD has received 5 research payments totaling $60,991.
Dr. Sanjay Chandrasekaran specializes in adult oncology and medical oncology. Areas of expertise for Dr. Chandrasekaran include soft tissue problems, sarcoma (bone and soft tissue cancer), and melanoma. He is professionally affiliated with UT Southwestern Medical Center. Dr. Chandrasekaran attended the University of Washington School of Medicine and then went on to complete his residency at a hospital affiliated with Emory University. He has received the following distinctions: Paul Carbone, MD Fellowship Award 2020, ECOG-ACRIN Cancer Research Group; Merit Award; and Conquer Cancer Foundation of American Society of Clinical Oncology.
